Avadel Pharmaceuticals
AVDL
#4636
Rank
A$3.04 B
Marketcap
A$31.01
Share price
0.16%
Change (1 day)
136.99%
Change (1 year)

Earnings for Avadel Pharmaceuticals (AVDL)

Earnings in 2025 (TTM): -A$5.79 Million

According to Avadel Pharmaceuticals 's latest financial reports the company's current earnings are A$0.24 Billion. In 2024 the company made an earning of -A$70.45 Million, an increase over its 2023 earnings that were of -A$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Avadel Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$5.79 Million-91.79%
2024 -A$70.45 Million-69.47%
2023 -A$0.24 Billion44.27%
2022 -A$0.16 Billion19.64%
2021 -A$0.14 Billion1732.84%
2020 -A$7.3 Million-86.83%
2019 -A$55.39 Million-65.92%
2018 -A$0.17 Billion-222.16%
2017 A$0.13 B-1053.49%
2016 -A$13.95 Million-112.59%
2015 A$0.11 B-185.94%
2014 -A$0.13 Billion66.04%
2013 -A$77.65 Million582.16%
2012 -A$11.39 Million-7.6%
2011 -A$12.32 Million-2.1%
2010 -A$12.59 Million32.52%
2009 -A$9.5 Million-64.36%
2008 -A$26.65 Million-52.93%
2007 -A$56.6 Million5.66%
2006 -A$53.57 Million17.86%
2005 -A$45.45 Million-375.09%
2004 A$16.52 M-406.44%
2003 -A$5.4 Million-145.2%
2002 A$11.92 M-363.36%
2001 -A$4.53 Million-80.62%
2000 -A$23.38 Million132.68%
1999 -A$10.05 Million-50.34%
1998 -A$20.23 Million54.85%
1997 -A$13.07 Million-28.35%
1996 -A$18.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.23 Billion 4,798.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$26.07 Million 457.62%๐Ÿ‡บ๐Ÿ‡ธ USA